Message #65 From:
NewsBot Date: January 19, 2007 06:55:00 AM
EFSF News eFoodSafety.com Announces That Cinnergen(TM) Has Added USA Drug and Dr. Leonard's to Its Growing List of Retail Distributors
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB:EFSF), a Company dedicated to improving
health conditions around the world through innovative products and
technologies, today announced that after a very successful clinical
study demonstrating the effectiveness of Cinnergen™
on diabetes, many other distributors have been requesting the product
for resale. Cinnergen™ is an all natural
liquid nutritional supplement designed to regulate blood sugar.
USA Drug (www.usadrug.com), a
family-owned and operated company, provides a down-home friendly,
atmosphere, while designed to handle a large number of retail customers.
USA Drug strives to maintain a continuously evolving retail format to
better provide its customers the best products and services at the
lowest competitive prices.
Dr. Leonard’s Healthcare (www.drleonards.com)
is a leading catalog healthcare provider offering a large selection of
healthcare products encouraging people to keep fit and strong. From
providing pills and supplements to improve one’s
overall health, Dr. Leonard’s is there for its
customers, ensuring that consumers have available all of their necessary
vitamins, nutrients and supplements.
Patricia Gruden, President and CEO of eFoodSafety.com, Inc., stated, “We
are continuing to aggressively build our Cinnergen™
retail distribution network. As part of this initiative, we are pleased
to add USA Drug and Dr. Leonard’s to our
growing list of premier vendors. We believe these combined with the
recent additions of Kroger’s, Kerr Drugs and
Cardinal Health all bode very well for increasing Cinnergen™
sales volumes as well as presenting an established distribution network
with potential future cross-selling opportunities.”
Mrs. Gruden further commented, “We anticipate
that with the clinical study now successfully completed, with the
results demonstrating Cinnergen’s
effectiveness on all types of diabetes, that our goal of having this
product in over 20,000 retail locations by the end of 2007 is attainable”
About eFoodSafety.com, Inc.
eFoodSafety.com, Inc. is dedicated to improving health conditions around
the world through its innovative technologies. The company’s
Knock-Out Technologies, Ltd. subsidiary has developed an environmentally
safe sporicidal product formulated entirely of food-grade components
that eradicates anthrax and a germicidal product, Citroxin (formerly
named Big Six Plus) -- EPA Reg. No. 82723-1 that kills six major
bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and
Streptococcus, Avian Influenza, and Black Mold. The sporicidal product
has completed its final efficacy laboratory study requisite for EPA
registration. In the study, it eradicated both Clostridium Sporogenes
and Bacillus Subtilis with 100% efficacy on both hard and porous
surfaces. The company’s MedElite, Inc.
subsidiary distributes clinically proven products to physicians who then
prescribe the products for their patients. It recently became the owner
of the Talsyn™-CI/bid Scar Cream, that has
been clinically proven to facilitate and improve the appearance, redness
and strength of scars (www.talsyn.com),
as well as seven (7) other products in the Talsyn™
line. The company is also owner of Cinnergen™,
a clinically-studied, non-prescription liquid whole food nutritional
supplement that promotes healthy glucose metabolism (www.cinnergen.com).
The company has entered into a joint venture agreement with CK41 Direct,
Inc. to launch the PurEffect™ anti-acne skin
care system.
Statements contained in this release that are not strictly historical
are “forward-looking”
statements within the meaning of Section 27A of the Securities Act of
1933 as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended. The forward-looking statements are made based on information
available as of the date hereof, and the Company assumes no obligation
to update such forward-looking statements. Editors and investors are
cautioned that such forward-looking statements involve risks and
uncertainties and the company’s actual
results may differ from these forward-looking statements. Such risks and
uncertainties include but are not limited to demand for the Company’s
products and services, our ability to continue to develop markets,
general economic conditions, our ability to secure additional financing
for the Company and other factors that may be more fully described in
reports to shareholders and periodic filings with the Securities and
Exchange Commission.
